RTW Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,582,396
| Closed | -$153M | – | 135 |
|
|
2021
Q3 | $153M | Buy |
7,582,396
+60,537
| +0.8% | +$1.67M | 2.31% | 13 |
|
|
2021
Q2 | $281M | Buy |
7,521,859
+58,568
| +0.8% | +$1.8M | 4.24% | 4 |
|
|
2021
Q1 | $191M | Buy |
7,463,291
+209,434
| +3% | +$5.35M | 2.98% | 7 |
|
|
2020
Q4 | $160M | Buy |
7,253,857
+26,444
| +0.4% | +$582K | 2.68% | 8 |
|
|
2020
Q3 | $130M | Buy |
7,227,413
+74,495
| +1% | +$1.54M | 3.13% | 6 |
|
|
2020
Q2 | $182M | Buy |
7,152,918
+189,783
| +3% | +$4.09M | 5.11% | 4 |
|
|
2020
Q1 | $128M | Buy |
6,963,135
+1,088,906
| +19% | +$21.2M | 5.51% | 4 |
|
|
2019
Q4 | $129M | Sell |
5,874,229
-328,196
| -5% | -$6.6M | 4.88% | 4 |
|
|
2019
Q3 | $89.1M | Buy |
6,202,425
+50,322
| +0.8% | +$719K | 5.3% | 4 |
|
|
2019
Q2 | $96.9M | Sell |
6,152,103
-70,933
| -1% | -$965K | 5.18% | 4 |
|
|
2019
Q1 | $91.2M | Buy |
6,223,036
+315,948
| +5% | +$3.63M | 6.22% | 3 |
|
|
2018
Q4 | $63.1M | Buy |
5,907,088
+445,964
| +8% | +$5.87M | 5.79% | 4 |
|
|
2018
Q3 | $83.3M | Buy |
5,461,124
+416,311
| +8% | +$6.06M | 4.99% | 5 |
|
|
2018
Q2 | $61.8M | Buy |
5,044,813
+15,351
| +0.3% | +$193K | 4.46% | 6 |
|
|
2018
Q1 | $48.1M | Sell |
5,029,462
-6,200
| -0.1% | -$66.8K | 4.58% | 7 |
|
|
2017
Q4 | $44.1M | Buy |
5,035,662
+2,956,671
| +142% | +$21.8M | 7.37% | 5 |
|
|
2017
Q3 | $12M | Hold |
2,078,991
| – | – | 2.08% | 15 |
|
|
2017
Q2 | $6.59M | Buy |
2,078,991
+16,000
| +0.8% | +$50.5K | 1.39% | 19 |
|
|
2017
Q1 | $7.01M | Buy |
2,062,991
+19,775
| +1% | +$55.7K | 1.85% | 17 |
|
|
2016
Q4 | $5.88M | Buy |
2,043,216
+16,322
| +0.8% | +$58K | 2.21% | 13 |
|
|
2016
Q3 | $11.9M | Hold |
2,026,894
| – | – | 3.6% | 8 |
|
|
2016
Q2 | $6.08M | Hold |
2,026,894
| – | – | 2.08% | 15 |
|
|
2016
Q1 | $10.9M | Buy |
2,026,894
+14,232
| +0.7% | +$89.8K | 3.94% | 8 |
|
|
2015
Q4 | $23.9M | Buy |
2,012,662
+7,424
| +0.4% | +$84.9K | 7.77% | 5 |
|
|
2015
Q3 | $16.5M | Buy |
2,005,238
+725,352
| +57% | +$8.38M | 5.12% | 8 |
|
|
2015
Q2 | $17.9M | Buy |
1,279,886
+288,905
| +29% | +$5.3M | 5.2% | 8 |
|
|
2015
Q1 | $23.8M | Sell |
990,981
-125,000
| -11% | -$2.81M | 10.75% | 3 |
|
|
2014
Q4 | $18.4M | Buy |
+1,115,981
| New | +$12.9M | 6.8% | 8 |
|
Other funds holding DRNA
RTW Investments's DRNA Position: Q4 2021 in Review
RTW Investments sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 7,582,396 shares — an estimated $153M sold.
RTW Investments first reported a position in DRNA in Q4 2014 and held it in 28 quarters. The position peaked at $281M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- RTW Investments reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- RTW Investments sold 7,582,396 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $153M.
- RTW Investments first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2014 and held it in 28 quarters.
- RTW Investments's Dicerna Pharmaceuticals, Inc. position peaked at $281M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on RTW Investments's 13F filing for Q4 2021, filed 14 Feb 2022.